EUVIMEDEUVIMED entdecken
Crossref

Nasopharyngeal Carcinoma in Intensity‐Modulated Radiation Therapy Era: Competing‐Risk Analysis, Recurrence, and Postrecurrence Survival

Chun-Wei Wang, Bing-Shen Huang, Hsiang-Kuang Liang, Wan-Yu Chen iD

Head & Neck · 2025

DOI: 10.1002/hed.28228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Chun-Wei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Neoplasm Recurrence, Local, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study assessed long‐term outcomes in nasopharyngeal carcinoma (NPC) patients treated with modern intensity‐modulated radiation therapy (IMRT), focusing on recurrence patterns and postrecurrence survival (PRS).

Methods

A cohort of 1554 NPC patients treated with definitive radiotherapy or concurrent chemoradiotherapy (CCRT) between 2005 and 2019 was analyzed using competing‐risk models. Cumulative incidences of recurrence or death, local recurrence or death, regional recurrence or death, and distant recurrence or death were calculated, with subgroup differences evaluated by Gray's test. PRS was assessed using Kaplan–Meier curves, log‐rank tests, and Cox proportional hazards models.

Results

The 3‐, 5‐, and 10‐year cumulative incidences of recurrence or death were 0.143, 0.162, and 0.187. T4 tumors showed poorer local control, and cumulative incidences of distant recurrence or death correlated with N classification. Most recurrences occurred within 2–3 years, with distant recurrences significantly reducing PRS.

Conclusion

IMRT provides excellent local‐regional control but requires improvement for T4 tumors and distant recurrences affecting PRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedNeoplasm Recurrence, LocalNasopharyngeal CarcinomaNasopharyngeal NeoplasmsHumansMaleFemaleMiddle AgedAdultRisk AssessmentAgedRetrospective StudiesChemoradiotherapyKaplan-Meier EstimateProportional Hazards ModelsYoung Adult

Stichwörter der Autor:innen

intensity‐modulated radiation therapynasopharyngeal carcinomapostrecurrence survivalrecurrence patternstreatment outcomes

Autor:innen und Institutionen

  • Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Department of Radiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
  • Department of Radiation Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.

ORCID-Profile: Wan-Yu Chen

Zitieren

APA

Wang, C. W., Huang, B. S., Liang, H. K., & Chen, W. Y. (2025). Nasopharyngeal Carcinoma in Intensity‐Modulated Radiation Therapy Era: Competing‐Risk Analysis, Recurrence, and Postrecurrence Survival. Head & Neck. https://doi.org/10.1002/hed.28228

Vancouver

Wang CW, Huang BS, Liang HK, Chen WY. Nasopharyngeal Carcinoma in Intensity‐Modulated Radiation Therapy Era: Competing‐Risk Analysis, Recurrence, and Postrecurrence Survival. Head & Neck. 2025. doi:10.1002/hed.28228

BibTeX
@article{Wang2025,
  author = {Wang, Chun-Wei and Huang, Bing-Shen and Liang, Hsiang-Kuang and Chen, Wan-Yu},
  title = {Nasopharyngeal Carcinoma in Intensity‐Modulated Radiation Therapy Era: Competing‐Risk Analysis, Recurrence, and Postrecurrence Survival},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28228}
}
Kostenlos starten →